Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Mailed Abortion Pills Found To Be Safe Ahead Of US Ruling

Abortions administered as pills sent in the mail are just as safe and effective as those provided in person, a US study said Thursday ahead of a Supreme Court ruling on restricting the medication.

International Business Times · Feb 15, 2024

Abortion pills that patients got via telehealth and the mail are safe, study finds

The study looks at 6,000 patients who got abortion pills after an online appointment. It found that 99.7% of those abortions were not followed by any serious adverse events.

WEKU · Feb 15, 2024

Telehealth abortions are as safe and effective as in-person, large study shows

An analysis of more than 6,000 telehealth abortion recipients in the U.S. suggests that receiving the abortion drugs via a virtual doctor's appointment is as safe and effective as doing so in person.

LiveScience · Feb 15, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

US FDA Approves First Treatment for Severe Frostbite

The US FDA has approved the first-ever treatment for severe frostbite, a breakthrough for victims of this debilitating condition.

1 Pharma Stock to Buy Near 52-Week Highs

GSK's stock has been a poor performer for years. But recently, the pharma stock keeps setting new 52-week highs, thanks to its blockbuster vaccines.

Barchart · Feb 14, 2024

FDA approves new chemotherapy treatment for pancreatic cancer patients

Learn about the FDA-approved chemotherapy treatment for pancreatic cancer that offers hope to patients, with insights from experts and real-life survivor s...

This device gives you a full health check up in a minute, and it's smaller than a smartphone

The Withings BeamO can be used by up to 8 users in the same household

T3 · Feb 14, 2024

Read news from The Economist, FT, and more,
with one subscription

FDA Warns Online Vendors Selling Misbranded Weight-Loss and Diabetes Drugs

The FDA issues warnings to online vendors selling misbranded weight-loss and diabetes drugs, highlighting potential health risks and illegal practices.

Samsung Galaxy Watch receives FDA authorization for Sleep Apnea Feature

Samsung's sleep apnea feature on the Galaxy Watch has received FDA authorization, allowing users to detect signs of sleep apnea and seek medical care.

It's Not Too Late to Buy Eli Lilly Stock. Here's Why.

J.P. Morgan thinks sales of weight-loss drugs could exceed $100 billion by 2030. That's good news for Eli Lilly, which is now the largest pharma company by market capitalization and the 9th-biggest S&P 500 stock. Here's why LLY stock looks poised to put on even more weight in the months…

Barchart · Feb 10, 2024

Galaxy Watch to detect signs of sleep apnea as the FDA gives the all-clear

Samsung's Galaxy Watch will be able to detect signs of sleep apnea in the U.S. as the FDA gives its approval.

Android Central · Feb 9, 2024

Why Investors Are Flocking to These 2 Medical Stocks

Given the growing demand for healthcare facilities, rapid integration of digital technology, and transformative biotechnology breakthroughs, the medical industry is poised for continued growth and profitability this year and beyond. Amid this, let’s find out why investors are flocking to medical stocks Vertex Pharmaceuticals (VRTX) and McKesson (MCK). Read more….

StockNews.com · Feb 9, 2024

Research at the heart of a federal case against the abortion pill has been retracted

A research paper that raises questions about the safety of abortion has been retracted. The research is cited in a federal judge's ruling about the abortion pill mifepristone.

WEKU · Feb 9, 2024

"Junk" abortion pill studies retracted

“I hope that this will make people more careful about when they cite studies," one lawyer told Salon

Salon · Feb 8, 2024

Get all your
news in one place.

100's of premium titles.
One news app.

Reason · Feb 7, 2024

Rachel Nuwer: MDMA Is On the Cusp of Legalization

In 2024, the FDA will decide whether or not MDMA can be used to treat patients suffering from PTSD.

Salon · Feb 6, 2024

Unregulated supplements can be harmful

The myriad potential harms of these products are wide-ranging

WEKU · Feb 6, 2024

FDA move to ban formaldehyde in hair straighteners called too little, too late

The FDA will soon move to ban formaldehyde in hair-straightening products. It's more than a decade after research raised alarms about health risks and other worrying chemicals remain in the products.

The Hindu · Feb 3, 2024

FDA busts bogus medicine racket; seizes 21,600 'antibiotic' tablets at Nagpur hospital

“The Maharashtra Food and Drug Administration (FDA) has exposed a bogus medicine racket and seized 21,600 tablets that had been passed off as ‘antibiotic ciprofloxacin’ from a government hospital in Nagpur,” an official said.

Get all your
news in one place.

100's of premium titles.
One news app.

Kiplinger · Feb 2, 2024

Dry January Can Boost Weed Sales: This Week in Cannabis Investing

Reports indicate the annual trend of giving up alcohol in January can help increase recreational cannabis sales.

Terry Dubrow endorses Ozempic for weight loss, dismisses Tylenol dangers

Terry Dubrow, star of Botched, advocates for the use of Ozempic for weight loss, claiming it is safer than Tylenol and effective in treating obesity.

StockNews.com · Feb 2, 2024

3 Lucrative Pharma Stocks for Portfolio Success

The pharmaceutical industry holds immense promise due to the rapidly aging population, growing healthcare needs, breakthroughs in new drugs and therapies, and the rise in chronic diseases. Therefore, it could be wise to add fundamentally strong pharma stocks Supernus Pharmaceuticals (SUPN), Eton Pharmaceuticals (ETON), and Viatris (VTRS) to one’s portfolio.…

Salon · Feb 2, 2024

FTC probe drugmakers’ patent thickets

The Federal Trade Commission has challenged more than 100 patents drugmakers listed in the FDA’s “Orange Book"

Salon · Feb 1, 2024

Restricting abortion drug access

The Supreme Court will soon decide the fate of access for mifepristone. The fallout of a ban would be tremendous

WEKU · Feb 1, 2024

Up First briefing: Houses passes child tax credit bill; EU agrees on Ukraine aid

The House approved a bipartisan bill that would expand the child tax credit. As tensions between Zelenskyy and his military chief rise, the EU agrees to more than $50 billion in aid for Ukraine.

International Business Times · Jan 31, 2024

Biogen Pulls Controversial Alzheimer's Drug Aduhelm

A controversial Alzheimer's drug that was trumpeted as the first to ever treat the cognitive decline associated with the devastating brain disorder has been pulled from the market, its maker Biogen announced Wednesday.

1 … 175 176 177 178

Coverage From

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Federal Trade Commission

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.